L2L-90129-98887
2 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 322 / FL
- Registered
- 2021-03-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Dose 1 — Pfizer-BioNTech
-
2021-03-13
Registered in v-safe
- 2021-03-13
- 2021-03-16
-
2021-03-22
Dose 2 — Pfizer-BioNTech
-
2021-03-22
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to workAdult check-in
- 2021-03-24
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-28
- 2021-03-29
- 2021-04-05
- 2021-04-12
-
2021-09-20
Survey response — 6 months, dose 2MedDRA: Fatigue, Headache, Oropharyngeal pain — Feeling: FairFree text: Sore throat, headache, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech | |
| 2 | 2021-03-22 | Pfizer-BioNTech |
Free text
Release 9 — 6 months, dose 2
Symptoms: Sore throat, headache, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release